Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Narendran

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Indian Journal of Chest Diseases & Allied Sciences|November 1, 2005
Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosisSoumya Swaminathan, C Padmapriyadarsini, G Narendran, et al.
The Indian Journal of Medical Research|November 28, 2009
CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosisK Alagarasu, P Selvaraj, S Swaminathan, et al.
International Journal of Immunogenetics|April 28, 2009
Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosisS Raghavan, P Selvaraj, S Swaminathan, et al.
The Journal of the Association of Physicians of India|December 4, 2010
Morphologic and body composition changes are different in men and women on generic combination antiretroviral therapy--an observational studyC Padmapriyadarsini, S Swaminathan, M J Karthipriya, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 10, 2015
RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatmentA K Hemanth Kumar, G Narendran, R S Kumar, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|January 25, 2008
Steady-State Pharmacokinetics of Nevirapine in HIV-1 Infected Adults in IndiaGeetha Ramachandran, A K Hemanthkumar, S Rajasekaran, et al.
The Indian Journal of Tuberculosis|March 20, 2014
HIV-infected patients retreated for tuberculosis with intermittent Category II regimen--treatment outcome at 24-month follow-upRamesh Kumar, Pradeep A Menon, C Ponnuraja, et al.
The Indian Journal of Medical Research|November 28, 2009
Pharmacokinetics of lamivudine & stavudine in generic fixed-dose combinations in HIV-1 infected adults in IndiaA K Hemanth Kumar, Geetha Ramachandran, S Rajasekaran, et al.
The Indian Journal of Medical Research|September 27, 2017
Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapyC Padmapriyadarsini, K Ramesh, L Sekar, et al.
Antimicrobial Agents and Chemotherapy|January 7, 2009
CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South IndiaGeetha Ramachandran, A K Hemanth Kumar, Sikhamani Rajasekaran, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Indian Journal of Chest Diseases & Allied Sciences|November 1, 2005
Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosisSoumya Swaminathan, C Padmapriyadarsini, G Narendran, et al.
The Indian Journal of Medical Research|November 28, 2009
CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosisK Alagarasu, P Selvaraj, S Swaminathan, et al.
International Journal of Immunogenetics|April 28, 2009
Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosisS Raghavan, P Selvaraj, S Swaminathan, et al.
The Journal of the Association of Physicians of India|December 4, 2010
Morphologic and body composition changes are different in men and women on generic combination antiretroviral therapy--an observational studyC Padmapriyadarsini, S Swaminathan, M J Karthipriya, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 10, 2015
RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatmentA K Hemanth Kumar, G Narendran, R S Kumar, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|January 25, 2008
Steady-State Pharmacokinetics of Nevirapine in HIV-1 Infected Adults in IndiaGeetha Ramachandran, A K Hemanthkumar, S Rajasekaran, et al.
The Indian Journal of Tuberculosis|March 20, 2014
HIV-infected patients retreated for tuberculosis with intermittent Category II regimen--treatment outcome at 24-month follow-upRamesh Kumar, Pradeep A Menon, C Ponnuraja, et al.
The Indian Journal of Medical Research|November 28, 2009
Pharmacokinetics of lamivudine & stavudine in generic fixed-dose combinations in HIV-1 infected adults in IndiaA K Hemanth Kumar, Geetha Ramachandran, S Rajasekaran, et al.
The Indian Journal of Medical Research|September 27, 2017
Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapyC Padmapriyadarsini, K Ramesh, L Sekar, et al.
Antimicrobial Agents and Chemotherapy|January 7, 2009
CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South IndiaGeetha Ramachandran, A K Hemanth Kumar, Sikhamani Rajasekaran, et al.
Pageof 3